Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism von Boon, Gudula J A M, Rein, Nienke van, Bogaard, Harm Jan, Ende-Verhaar, Yvonne M, Huisman, Menno V, Kroft, Lucia J M, Meer, Felix J M van der, Meijboom, Lilian J, Symersky, Petr, Vonk Noordegraaf, Anton, Klok, Frederikus A

Volltext

Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort von Camilleri, Eleonora, Ghobreyal, Mira, Bos, Mettine H. A., Reitsma, Pieter H., Van Der Meer, Felix J. M., Swen, Jesse J., Cannegieter, Suzanne C., Rein, Nienke

Volltext

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment von Kooiman, Judith, van Hagen, Nadja, Iglesias Del Sol, Antonio, Planken, Erwin V, Lip, Gregory Y H, van der Meer, Felix J M, Cannegieter, Suzanne C, Klok, Frederikus A, Huisman, Menno V

Volltext

Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists von van Rein, Nienke, Lijfering, Willem M, Bos, Mettine H A, Herruer, Martien H, Vermaas, Helga W, van der Meer, Felix J M, Reitsma, Pieter H

Volltext

Correction: Quality of initial anticoagulant treatment and risk of CTEPH after acute pulmonary embolism von Boon, Gudula J. A. M, van Rein, Nienke, Bogaard, Harm Jan, Ende-Verhaar, Yvonne M, Huisman, Menno V, Kroft, Lucia J. M, van der Meer, Felix J. M, Meijboom, Lilian J, Symersky, Petr, Noordegraaf, Anton Vonk, Klok, Frederikus A

Volltext

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study von Toorop, Myrthe M. A., Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.

Volltext

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon von Verhoef, Talitha I, Ragia, Georgia, de Boer, Anthonius, Barallon, Rita, Kolovou, Genovefa, Kolovou, Vana, Konstantinides, Stavros, Le Cessie, Saskia, Maltezos, Efstratios, van der Meer, Felix J.M, Redekop, William K, Remkes, Mary, Rosendaal, Frits R, van Schie, Rianne M.F, Tavridou, Anna, Tziakas, Dimitrios, Wadelius, Mia, Manolopoulos, Vangelis G, Maitland-van der Zee, Anke H

Volltext

Association of VKORC1 polymorphisms and major bleedings in patients who are treated with vitamin K antagonists von Heteren, D. Max, Lijfering, Willem M., Meer, Felix J. M., Reitsma, Pieter H., Swen, Jesse J., Bos, Mettine H. A., Rein, Nienke

Volltext

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence? von Toorop, Myrthe M. A., Chen, Qingui, Kruip, Marieke J. H. A., Meer, Felix J. M., Nierman, Melchior C., Faber, Laura, Goede, Lies, Cannegieter, Suzanne C., Lijfering, Willem M.

Volltext

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial von Schol‐Gelok, Suzanne, Maat, Moniek P. M., Biedermann, Joseph S., Gelder, Teun, Leebeek, Frank W. G., Lijfering, Willem M., Meer, Felix J. M., Rijken, Dingeman C., Versmissen, Jorie, Kruip, Marieke J. H. A.

Volltext

Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data von Hollestelle, Martine J., van der Meer, Felix J.M., Meijer, Piet

Volltext

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns von Toorop, Myrthe M. A., Rein, Nienke, Nierman, Melchior C., Vermaas, Helga W., Huisman, Menno V., Meer, Felix J. M., Cannegieter, Suzanne C., Lijfering, Willem M.

Volltext

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data von van Schie, Rianne M.F., Wessels, Judith A.M., le Cessie, Saskia, de Boer, Anthonius, Schalekamp, Tom, van der Meer, Felix J.M., Verhoef, Talitha I., van Meegen, Erik, Rosendaal, Frits R., Maitland-van der Zee, Anke-Hilse

Volltext

Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy von Rombouts, Eva K., Rosendaal, Frits R., Van Der Meer, Felix J. M.

Volltext

Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands von Eckhardt, Corien L., Mauser-Bunschoten, Evelien P., Peters, Marjolein, Leebeek, Frank W. G., van der Meer, Felix J. M., Fijnvandraat, Karin

Volltext

Adherence to direct oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study von Zielinski, Gilda D., Rein, Nienke, Teichert, Martina, Klok, Frederikus A., Rosendaal, Frits R., Meer, Felix J. M., Huisman, Menno V., Cannegieter, Suzanne C., Lijfering, Willem M.

Volltext

Effect of multidose drug dispensing on the time in therapeutic range in patients using vitamin‐K antagonists: A randomized controlled trial von Mertens, Bram J., Kwint, Henk‐Frans, Belitser, Svetlana V., Meer, Felix J. M., Marum, Rob J., Bouvy, Marcel L.

Volltext

A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program von Poller, Leon, Keown, Michelle, Ibrahim, Saied, Lowe, Gordon, Moia, Marco, Turpie, Alexander G., Roberts, Christopher, van den Besselaar, Anton M. H. P., van der Meer, Felix J. M., Tripodi, Armando, Palareti, Gualtiero, Shiach, Caroline, Bryan, Stirling, Samama, Meyer, Burgess-Wilson, Michael, Heagerty, Anthony, MacCallum, Peter, Wright, David, Jespersen, Jørgen

Volltext

Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma von van den Besselaar, Anton M. H. P., Witteveen, Evelina, van der Meer, Felix J. M.

Volltext

Subtherapeutic oral anticoagulant therapy: Frequency and risk factors von Rombouts, Eva K., Rosendaal, Frits R., van der Meer, Felix J. M.

Volltext